Correlation Engine 2.0
Clear Search sequence regions

Micafungin is a relatively broad-spectrum antifungal agent available for clinical use in the US and Japan. By inhibiting the production of beta-1,3-glucan, an essential fungal cell wall component, micafungin has reduced toxicity to mammalian cells while maintaining potent antifungal activity against many pathogenic fungi including polyene- and azole-resistant isolates. Indeed, micafungin has been shown to be efficacious in the treatment of infections caused by Candida and Aspergillus species in clinical trials without the associated toxicities of amphotericin B formulations and drug interactions that occur with the azoles. In this review, the pharmacology, spectrum of activity, clinical efficacy and safety profile of micafungin are discussed.


Nathan P Wiederhold, James S Lewis. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety. Expert opinion on pharmacotherapy. 2007 Jun;8(8):1155-66

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 17516879

View Full Text